81 related articles for article (PubMed ID: 10800483)
1. New anticancer agents.
Britten C; Hammond L; Hidalgo M; Rothenberg ML; Sharma A; Sharma S; Siu L; Villalona-Calero M; Weiss GR
Cancer Chemother Biol Response Modif; 1999; 18():178-209. PubMed ID: 10800483
[No Abstract] [Full Text] [Related]
2. New anticancer agents.
Weiss GR; Burris HA; Eckhardt SG; Rodriguez GI; Sharma S; Valley A
Cancer Chemother Biol Response Modif; 1997; 17():178-94. PubMed ID: 9551214
[No Abstract] [Full Text] [Related]
3. Novel approaches for targeting thymidylate synthase to overcome the resistance and toxicity of anticancer drugs.
Garg D; Henrich S; Salo-Ahen OM; Myllykallio H; Costi MP; Wade RC
J Med Chem; 2010 Sep; 53(18):6539-49. PubMed ID: 20527892
[No Abstract] [Full Text] [Related]
4. Synthesis and discovery of N-carbonylpyrrolidine- or N-sulfonylpyrrolidine-containing uracil derivatives as potent human deoxyuridine triphosphatase inhibitors.
Miyakoshi H; Miyahara S; Yokogawa T; Chong KT; Taguchi J; Endoh K; Yano W; Wakasa T; Ueno H; Takao Y; Nomura M; Shuto S; Nagasawa H; Fukuoka M
J Med Chem; 2012 Apr; 55(7):2960-9. PubMed ID: 22404301
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel class of potent human deoxyuridine triphosphatase inhibitors remarkably enhancing the antitumor activity of thymidylate synthase inhibitors.
Miyahara S; Miyakoshi H; Yokogawa T; Chong KT; Taguchi J; Muto T; Endoh K; Yano W; Wakasa T; Ueno H; Takao Y; Fujioka A; Hashimoto A; Itou K; Yamamura K; Nomura M; Nagasawa H; Shuto S; Fukuoka M
J Med Chem; 2012 Apr; 55(7):2970-80. PubMed ID: 22339362
[TBL] [Abstract][Full Text] [Related]
6. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
Chu E; Chu MY; Darnowski JW; Chen ZH; Pan BC; Chu SH
Cancer Res; 1992 Apr; 52(7):1729-36. PubMed ID: 1532344
[TBL] [Abstract][Full Text] [Related]
8. [Studies on the mechanism of antitumor activity of 5-FU and its derivatives--relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo].
Nakamura H; Yu-Qin W; Miyauchi S; Nishioka N; Tanaka H; Harada N; Shirasaka T; Fujii S
Gan To Kagaku Ryoho; 1984 May; 11(5):1049-55. PubMed ID: 6426401
[TBL] [Abstract][Full Text] [Related]
9. European School of Oncology Task Force Report. New approaches in cancer pharmacology: drug design and development (Part 2).
Workman P; D'Incalci M; Bursch W; Harrap KR; Hawkins RE; Neidle S; Powis G
Eur J Cancer; 1994; 30A(8):1148-60. PubMed ID: 7654448
[No Abstract] [Full Text] [Related]
10. Cellular processing of platinum anticancer drugs.
Wang D; Lippard SJ
Nat Rev Drug Discov; 2005 Apr; 4(4):307-20. PubMed ID: 15789122
[TBL] [Abstract][Full Text] [Related]
11. [Cleavage of DNA after modification with tetravalent platinum compounds].
Astashkina TG; Vlasov VV; Kazakov SA; Tsvetkov IV
Dokl Akad Nauk SSSR; 1988; 301(1):234-6. PubMed ID: 3181005
[No Abstract] [Full Text] [Related]
12. Activating platinum anticancer complexes with visible light.
Berners-Price SJ
Angew Chem Int Ed Engl; 2011 Jan; 50(4):804-5. PubMed ID: 21246674
[No Abstract] [Full Text] [Related]
13. Novel targets for therapy in paediatric oncology.
Estlin EJ
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):141-50. PubMed ID: 12476788
[TBL] [Abstract][Full Text] [Related]
14. Proceedings: Inhibitors of thymidylate synthetase as R factor curing agents.
Bremer K; Pinney RJ; Smith JT
J Pharm Pharmacol; 1973 Dec; 25():Suppl:131P-132. PubMed ID: 4150531
[No Abstract] [Full Text] [Related]
15. [Studies of the antitumor activity and enzymology of 2'-deoxy-5-fluorouridine (FdUrd) derivatives].
Fujii S; Shirasaka T
Gan No Rinsho; 1986 Apr; 32(4):379-82. PubMed ID: 2940387
[TBL] [Abstract][Full Text] [Related]
16. [Effects of camphoramine chloroacetic platinum (CCP) on DNA template].
Wang LG; Liu XM; Ji XJ
Yao Xue Xue Bao; 1987 Jan; 22(1):6-11. PubMed ID: 3604695
[No Abstract] [Full Text] [Related]
17. Perspectives on new chemotherapeutic agents in the treatment of colorectal cancer.
Clark JW
Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-19-S18-24. PubMed ID: 9420017
[TBL] [Abstract][Full Text] [Related]
18. Changes in microtubules and microfilaments due to a combined effect of ultrasound and cytostatics in HeLa cells.
Skorpíková J; Dolníková M; Hrazdira I; Janisch R
Folia Biol (Praha); 2001; 47(4):143-7. PubMed ID: 11508858
[TBL] [Abstract][Full Text] [Related]
19. [Oxaliplatin: perspectives and future developments].
Marty M; Cottu PH; Lerebours F; Bedairia N; Hocini H; Espié M
Bull Cancer; 2001 Aug; 88 Spec No():S5-8. PubMed ID: 11567907
[No Abstract] [Full Text] [Related]
20. Role of thymidine kinase and thymidylate synthetase in the cytostatic, antimetabolic, and antitumor effects of the carbocyclic analogue of 5-nitro-2'-deoxyuridine. A comparison with 5-nitro-2'-deoxyuridine.
Balzarini J; De Clercq E; Herdewijn P; Robins MJ
Mol Pharmacol; 1985 May; 27(5):578-83. PubMed ID: 3990680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
